Xia Jun, Yang Guanqun, Yu Qingling, Zhang Ruiyi, Li Ge, Wang Man, Sun Hongli, Chen Heng, Wang Lingling, Chen Ping, Gu Kai-Li, Sun Chao
Department of Hematology, Affiliated Wuxi People's Hospital, Nanjing Medical University, Wuxi, China.
Changshu Hospital Affiliated to Soochow University, Changshu NO.1 People's Hospital, Changshu, Jiangsu, China.
Front Oncol. 2024 Dec 10;14:1466590. doi: 10.3389/fonc.2024.1466590. eCollection 2024.
Acute myeloid leukemia (AML), which is most common in adults, is a challenging hematological malignancy. The occurrence and the progression of AML are often accompanied by various gene fusions and/or mutations. Herein, we report the first case of a fusion transcript with a translocation of (1;12)(q25;p13) in AML progressed from myelodysplastic syndrome (MDS) combined with an -ITD (internal tandem duplication) mutation. Further studies should focus on the biological functions of these novel chimeric products in disease onset and progression, as well as their potential as monitoring markers in disease regression.
急性髓系白血病(AML)在成年人中最为常见,是一种具有挑战性的血液系统恶性肿瘤。AML的发生和进展常伴有各种基因融合和/或突变。在此,我们报告了首例从骨髓增生异常综合征(MDS)进展而来的AML患者,其存在(1;12)(q25;p13)易位的融合转录本,并伴有内部串联重复(-ITD)突变。进一步的研究应聚焦于这些新型嵌合产物在疾病发生和进展中的生物学功能,以及它们作为疾病缓解监测标志物的潜力。